daunorubicin has been researched along with toremifene in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Nakamura, T; Ueda, T; Urasaki, Y | 1 |
| Komi, J; Lassila, O | 1 |
1 review(s) available for daunorubicin and toremifene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 other study(ies) available for daunorubicin and toremifene
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Circumvention of daunorubicin resistance by a new tamoxifen derivative, toremifene, in multidrug-resistant cell line.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Chemical Phenomena; Chemistry, Physical; Daunorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Humans; Leukemia, Myeloid; Membrane Glycoproteins; Phenotype; Solubility; Toremifene; Tumor Cells, Cultured; Verapamil | 1994 |
Toremifene increases the expression of intercellular adhesion molecule-1 (ICAM-1) on MCF-7 breast cancer cells and Jurkat cells.
Topics: Antineoplastic Agents, Hormonal; Apoptosis; B7-1 Antigen; Breast Neoplasms; CD40 Antigens; Daunorubicin; fas Receptor; Female; HLA-DR Antigens; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Jurkat Cells; Recombinant Proteins; Selective Estrogen Receptor Modulators; Toremifene; Tumor Cells, Cultured | 2000 |